Susceptibility trends in bacteraemias: Analyses of 7544 patient-unique bacteraemic episodes spanning 11 years (1990-2000)

Journal of Hospital Infection

Volumn 55, Issue 3, 2003, Pages 196-203

  Raveh, D ^a,b   Rudensky, B ^a,b   Schlesinger, Y ^a,b   Benenson, S ^a,b   Yinnon, A M ^a,b  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Antibiotics; Antimicrobials; Bacteraemia; Blood cultures; In vitro susceptibilities

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; METICILLIN; MEZLOCILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACCURACY; ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BLOOD CULTURE; CALCULATION; CANDIDA; CONTROLLED STUDY; DATA BASE; EMERGENCY WARD; ENTEROBACTER; ENTEROCOCCUS; ESCHERICHIA COLI; HOSPITAL ADMISSION; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; IN VITRO STUDY; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; PEDIATRICS; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SEPSIS; SPECIES; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; SURGICAL WARD;

ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIA; DATABASES, FACTUAL; DISEASE SUSCEPTIBILITY; HUMANS;

EID: 0348198170     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(03)00286-X     Document Type: Article

References (29)

1. Moellering R.C. Principles of anti-infective therapy In: Mandell G.L. Bennett J.E. Dolin R. (Eds.), Principles and Practice of Infectious Diseases 5th ed 2000 223-235 Churchill Livingstone Philadelphia
2. Joshi N. Mildred D. The use and misuse of new antibiotics Arch Intern Med 155 1995 569-577
3. Reese R.E. Betts R.F. Antibiotic use In: Reese R.E. Betts R.F. (Eds.), A Practical Approach to Infectious diseases 10th ed 1996 1059-1097 Little, Brown and Co Boston
4. Elhanan G. Sarhat M. Raz R. Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection J Infect 35 1997 283-288
5. Gransden W.R. Eykin S.J. Phillips I. Rowe B. Bacteremia due to Escherichia coli: a study of 861 episodes Rev Infect Dis 12 1990 1008-1018
6. Weinstein M.P. Reller L.B. Murphy J.R. Lichtenstein K.A. The clinical significance of positive blood cultures: a comprehensive analysis of 500 episodes of bacteremia and fungemia in adults. Laboratory and epidemiologic observations Rev Infect Dis 5 1983 35-53
7. Fridkin S.K. Hill H.A. Volkova N.V. et al. Temporal changes in prevalence of antimicrobial resistance in 23 US hospitals Emerg Infect Dis 8 2002 697-701
8. Yinnon A.M. Schlesinger Y. Gabbay D. Rudensky B. Importance of stratification of microbial susceptibilities by source of patients J Infect 35 1997 17-23
9. Bauer A.M. Kirby W.M.M. Sherris J.C. Turck M. Antibiotic susceptibility testing by a standard, simple disk method Am J Clin Pathol 45 1966 493-496
10. Murray P.R. Manual of Clinical Microbiology 6th ed 1995 ASM Press Washington, DC
11. Glantz S.A. Primer in Biostatistics 3rd ed. 1992 McGraw-Hill, Inc. New York
12. Snedecor GW Cochran WG Analysis of frequencies. In: Snedecor GW, Cochran WG, editors. Statistical Methods, 7th ed. Ames: Iowa University; 1980. p. 206-208.
13. Abramson J.H. Gahlinger M. Computer programs for epidemiologists: PEPI version 3 1999 Brixton Books Powys
14. Raveh D. Rudensky B. Huerta M. Aviv Y. Yinnon A.M. The use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection Eur J Clin Microbiol Infect Dis 22 2003 158-164
15. Pinner R.W. Teutsch S.M. Simonsen L. et al. Trends in infectious diseases mortality in the United States JAMA 275 1996 189-193
16. Simonsen L. Conn L.A. Pinner R.W. Teutsch S. Trends in infectious disease hospitalizations in the United States, 1980-1994 Arch Intern Med 158 1998 1923-1928
17. Hoyert D.L. Kochanek K.D. Murphy S.L. Death: dinal data for 1997. Vol 47 1999 National Center for Health Statistics Hyattsville, MD National Vital Statistics Reports, no. 19
18. McBean M. Rajamani S. Increasing rates of hospitalization due to septicemia in the US elderly population, 1986-1997 J Infect Dis 183 2001 596-603
19. Chamberland S. L'Ecuyer J. Lessard C. Bernier M. Provencher P. Bergeron M.G. Antibiotic susceptibility profiles of 941 Gram-negative bacteria isolated from septicemic patients throughout Canada Clin Infect Dis 15 1992 615-628
20. Yinnon A.M. Butnaru A. Raveh D. Jerassy Z. Rudensky B. Klebsiella bacteremia: community versus nosocomial infection Quart J Med 89 1996 933-941
21. Wong-Beringer A. Hindler J. Loeloff M. et al Molecular correlation for the treatment outcomes in bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae with reduced susceptibility to ceftazidime Clin Infect Dis 34 2002 135-146
22. Tsay R.W. Siu L.K. Fung C.P. Chang F.Y. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection Arch Intern Med 162 2002 1021-1027
23. Tallis E. Rudensky B. Attias D. Raveh D. Schlesinger Y. Yinnon A.M. In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of Gram-negative bacilli and Staphylococcus aureus Diagn Microbiol Infect Dis 35 1999 121-126
24. Paterson D.L. Ko W.C. Von Gottberg A. et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory J Clin Microbiol 39 2001 2206-2212
25. Livermore D.M. James D. Reacher M. et al. Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999 Emerg Infect Dis 8 2002 473-478
26. Paterson J.E. Hardin T.C. Kelly C.A. Garcia R.C. Jorgensen J.H. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae Infect Contr Hosp Epidemiol 21 2000 455-458
27. Harold B.C. Immergluck L.C. Maranan M.C. et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk JAMA 279 1998 593-598
28. Fergie J.E. Purcell K. Community-acquired methicillin-resistant Staphylococcus aureus infections in south Texas children Pediatr Infect Dis J 20 2001 860-863
29. Hussain F.M. Boyle-Vavra S. Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic Pediatr Infect Dis J 20 2001 763-767